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Summary.-The clinical features of acute leukaemia (AL) were documented pros-
pectively among Nigerian children resident in the South-Western rain-forest area of
the country, and compared to the features in Caucasians. Twenty-nine of 51 newly
diagnosed cases of AL occurred in childhood, including 19 cases of acute
lymphoblastic leukaemia (ALL) and 11 of acute myelogenous leukaemia (AML). The
incidence of ALL and AML in Ibadan children was the same, estimated as 0-8 x 10-5.
Thus childhood ALL was about one-third as common in Ibadan as in most developed
Caucasian countries. ALL and AML occurred most frequently in the age groups 10-14
and 5-9 years respectively. Six cases of AML were associated with chloromas. Only 2
of the ALL patients survived more than one year after standard chemotherapy. The
poor result appeared to be attributable to frequent occurrence among the ALL
patients of adverse prognostic factors such as hyperleucocytosis, age <2 or >7 years,
L2 morphology and low PAS reactivity ofthe lymphoblasts. Unknown environmental
factors are believed to be responsible for the unusual features of AL in children in
Ibadan.
THE CLINICAL AND LABORATORY FEAT-
URES of acute and chronic leukaemias, as
seen in various parts of the African
Continent, have been previously exten-
sively described (Allan & Watson-
Williams, 1963; Kasili & Taylor, 1970;
Lothe, 1967; Essien, 1972; Fleming, 1977,
Fleming, 1979). These reports not only
indicated the rarity ofacute lymphoblastic
leukaemia (ALL) in early years oflife, but
also the higher occurrence of acute myelo-
genous leukaemia (AML) in childhood. A
number of other reports have also des-
cribed the frequent occurrence of chloro-
mas in association with acute leukaemia
(AL) in African children (Barsoum, 1938;
Davies & Owor, 1965). The present report
seeks in particular to compare and con-
trast the clinical features of childhood AL
as seen in the children of Ibadan, Nigeria,
and their Caucasian counterparts in the
developed Western countries.
PATIENTS AND METHODS
All patients included in this report were
indigenous Nigerian residents in the tropical
rain-forest belt of the country. Most of the
patients resided in Ibadan, a city of about 1
million people. Some of the patients lived in
smaller neighbouring towns and villages. The
parents of most of the children were illiterate
peasant farmers or petty traders.
The patients were referred to the Univers-
ity College Hospital, Ibadan, where the
diagnosis of AL was established by the
determination of the packed-cell volume
(PCV), total and differential WBC count,
platelet count and examination of marrow
smears processed with May-Griinwald-
Giesma stain. In some cases, peripheral blood
and marrow films were stained for periodic
acid-Schiff (PAS) reaction, and, in a few
cases, with Sudan Black. Evaluation and
subtype classification was according to the
criteria of Hayhoe & Cawley (1972) and
Bennett et al. (1976). Lymphocyte surface
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markeIs were evaluated in a few cases, using
the routine techniques of SRBC rosette for-
mation for T cells and immunofluoreseence for
B lymphocytes. Other routine investigations
done included chest X-ray, i.v. pyelography,
skeletal survey and lumbar punctuire for CSF
examination.
In order to estimate the age-specific
incideince of AL for Ibadan, the present
population of the various age-groups were
computed from the figure of the last reliable
census conducted in the area, in 1963,
assuming an annual growth-rate of 2.-5°
(Fed. Office of Statistics. 1968), and the
absence of major shift in the population since
the last census. Despite their educational
handicaps, the parents ofthe children devised
various methods of remembering the year of
birth, if not the exact birthday of their
children.
The remission-induction regimen for ALL
consisted of vincristine (2 mg/m2/wk x 4, i.v.)
and prednisolone (40 mg/m2/day x 28, orally),
to which wNas added one of the following
agents: Adriamycin (20 mg/m2/day x 3),
Days 1-3) or cyclophosphamide (600 mg/m2/
wk x 2, i.v., Days 1 and 8) or cytosine
arabinoside (50 mg/M2 12-hourly x 14), each
dose being given as a continuous 3 h infusion.
Intrathecal methotrexate (12-5 mg/M2 in 2
doses) was given twice weekly, 5 days apart,
during remission induction. The course was
repeated if complete remission was not
achieved after the first course. All remitters
wxere subsequently placed on 6-mercapto-
TABLE I. Subtypes of acute leukaemnia in
Nigerian children of Ibadan area, 1978-
1981
Subtypes
LI
L2
L3
Unknown
Total
Pro
MAIM
MIy
Total
LI, L2, L= Cytologieal
Bennett et al., 1976).
Pro =Promyelocytie
rNr = Mlyelomonocyti.
Mly =Myeloblastic.
iMale Female
1 1
6 3
1 0
6 1
14 5
1 1
3 (3)* 0
4 (2) 1 (1)
9 (5) 2 (1)
ALL subtypes (see
* Numbers in parenthieses rel)resent eases
associate(l witl chiloroma.
purine (100 mg/m2/day orally) and metho-
trexate (12-5 mg/M2 orally twice weekly). At
3-monthly intervals, consolidation chemo-
therapy was given as i.v. Adriamycin (20 mg/
m2/day x 3), i.v. vincrinstine (2-0 mg/M2 on
Days 1 and 8) and oral prednisolone
(40 mg/m2/day for 14 days). Patients receiv-
ing the treatment regimen as described were
considered "adequately treated". Others who
for various reasons deviated significantly
from the regimen were considered "'inade-
quately treated". No patient received cranial
irradiation.
The treatment of AML w-as much less
organized and on the whole unsatisfactory.
mainly because ofthe sporadic availability of
the necessary drugs and difficulty in provid-
ing haematological supportive care as well as
appropriate antibiotic coverage.
RESULTS
Ofthe 51 newly diagnosed cases ofacute
leukaemia seen in the period July 1978 to
December 1981 at the U.C.H., Ibadan,
Nigeria, 29 (58%) occurred in children (i.e.
< 14 years old). The cytological classifica-
tion of the cases is shown in Table I.
Seventy-six per cent of all cases of ALL
and 39O% of all cases of AML occurred in
children. Childhood ALL was of "Null"-
cell type in 3, and T-cell type in 2 out of 5
cases investigated appropriately. These
and other clinical and laboratory features
in our ALL patients are shown in Table II.
The male:female ratio was 2 8: 1 and 4 5: ]
for childhood ALL and AML respectively.
The incidence of ALL and AML for all
childhood ages was about the same (i.e.
0*8 x 10-5) for the city of Ibadan. AML
occurred most frequent among boys ofthe
age group 5-9 years, while the incidence of
ALL was highest among boys of the age
group 10-14 years. A comparison of the
incidence of childhood AL in Ibadan with
reported data from some developed
countries (Table III) showed that the
marked peak incidence ofALL in the first
4 years oflife in the U.S. White and Black
children was not found in Ibadan. Further-
more, the relatively high incidence ofAML
in Ibadan children between the ages of 5
and 9 has not been reported recently in
ALL
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any Western Caucasian population. Simi-
larly, the high frequency of chloromas in
Ibadan children in association with AML
(6/11 (54%) for ages 0-14, and 62% for
ages 5-9) stands in sharp contrast to
reported data from Western Caucasian
populations (Table III). These chloromas
occurred in the ocular orbits in 3, oro-
pharynxin 2, meninges in 1 andthegenito-
urinary tract in 1 patient.
As shown in Table II, PCV in 10/15
children fell within the intermediate range
of 15-30% ('%5-10g/dl) and 11-14% in
the remaining 5. Hyperleucocytosis occur-
red in all but one child with a WBC count
< 1010/1 (Patient 16). Hepatosplenomegaly
of varying degrees was seen in 12 ALL
patients, including Patient 6 with a
normal WBC count. However, invasion of
the CNS, mediastinum, testes and kidneys
occurred only in association with marked
leucocytosis (WBC>1012/1) with the ex-
ception of Patient 9. LI, L2 and L3 cell
morphology was observed in 2, 9 and 1
patient respectively. PAS was strongly
positive ( 900%) in 3, weakly positive
(2-20%) in 3, andnegative in 6/12 patients
in whom the test was done.
Nine of 13 cases of ALL (69%) and 4/8
cases of AML (50%) achieved various
degrees of remission. Like all AML cases,
the duration of remission in most of the
ALL cases was short (62-160 days)
regardless of whether the children were
"adequately" treated. However, the
results in 2 ofthe ALL patients (Table II,
Patients 15 and 17) were relatively
encouraging. The duration of the first
remission in Patient 15 was 414 days; he
has now survived 12 years and is currently
in his second remission. Patient 17, who
was initially inadequately managed, re-
lapsed after 153 days, was re-induced into
remission and survived for a total of 423
days. These two patients are among the 3
with strong PAS block-positivity of their
lymphoblasts. Apart from having a low
WBC and blast-cell count, Patient 15 was
further distinguished from the rest by
having the largest and most numerous
PAS+ materials in his lymphoblasts.
Other unusual features of childhood AL
TABLE III.-Some features of childhood acute leukaemia in Ibadan contrasted with
reported datafrom Western Europe and U.S.A.
ALL
M/F ratio:
Median age in years (range)
M
F
Incidence ( x 10-5)
0-14
0-4 fyears
ALL/Wilms' tumour ratio
AML
M/F ratio:
Median age in years (range)
M
F
Incidence (x 10-5)
Chloromas
AML/Wilms' tumour ratio
Childhood leukaemia
Relative frequency among
childhood cancers
ALL/AML ratio
Ibadan
Nigeriaa
2-8
Manchester
Englandb
1 45
U.S.A.c.....
White
1-42
Black Swedend
1-5 1-37
6 (0- 8-14) 4j (2j-8)f
5j (4-61) 4 (2j-7)f
0-8
0-6
1*1
4.5
8 (6-14)
9-10
0-8
6/11
0.59
2-61
1-15
0-76
6j (3-121)f
7 (3 -10j)f
0O5
3/162
1 -31
2-46e
~5.0g
3 -27
1.09
0 74
1/114
0 97
1.29e
2 09
1 -67
0-83
0 47
0/11
0-61
3-73
1 -08
0 54
4th most most most most most
commonh common common common common
1-9 3.9 3-36 2-7 5-87
aThis study. bBirch et al. (1980). cYoung et al. (1975).5Ericsson et al. (1978). eDerived from dataprovided
by Young et al. (1975). fInterquartile range. gThird National cancer survey as cited by Henderson (1973).
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as seen in Ibadan are contrasted with data
published for Caucasian and Black Ameri-
can children in Table III. It appears that
the low incidence of ALL in Ibadan
children reflects a true deficit rather than
under-diagnosis. This is indicated by the
low ALL/Wilms' tumour ratio in Ibadan
and the U.S. Black children, since the
occurrence of Wilms' tumour is said to
vary little throughout the world (Miller,
1972; Williams, 1975). The low ALL/AML
ratio in Ibadan children may also reflect
the reduced incidence of ALL in the
population (Table III). Similarly, the
marked male excess in ALL and AML is
real and is at variance with the balanced
sex ratio seen in Wilms' tumour (Williams,
1975).
DISCUSSION
The demographic structure ofthe devel-
oping countries is characterized by a
disproportionately large child population
(Loraine, 1974). With almost 60% of all
cases of AL in this age group, it would
appear that the study of this group of
diseases is ofparamount importance to the
tropical African and, perhaps, other Third
World countries.
The contrasting features of AL in
Ibadan children vis-a'-vis Caucasian and
Black children of the U.S.A. and Europe
are shown in Table III. The low incidence
of ALL and the low ALL/Wilms' tumour
ratio in Ibadan and U.S.A. Black children
would tend to suggest a genetic role in
ALL pathogenesis. However, this is un-
likely to be a major determining factor, in
view of the observation that non-Cauca-
sian ethnic groups with low ALL incidence
tend to show a reversal in ALL incidence
pattern on acquiring Western life-style
(Henderson, 1973), which indicates a
possible role for environmental factors in
the aetiology of the disease. The incidence
of AML, as well as the AML/Wilms'
tumour ratio, do not show striking varia-
tions between Ibadan and U.S. Black
children on one hand, and Caucasian
children of Europe and the U.S.A. on the
other, thus suggesting aetiological simi-
larity. However, thefrequentassociationof
AML with chloromas in Ibadan children as
opposed to Western populations (Table
III) suggests a marked difference in
disease manifestation. Similar frequent
association ofAML and chloroma has been
reported from other parts of Africa
(Davies & Owor, 1965) and Turkey
(Cavdar et al., 1971) and a possible role has
been suggested for the Epstein-Barr virus
by Cavdar et al. (1973, unpublished) in the
aetiology of chloroma-associated AML in
Turkish children. It is interesting that in
an ethnically pluralistic society like South
Africa, the patterns of ALL and AML in
Caucasian and Black children follows the
trends outlined above (MacDougall &
Janowitz, 1981, unpublished), thus signi-
fying an association between childhoodAL
and the life-style of the society.
The poor response to treatment of ALL
in Ibadan children stands in sharp con-
trast to the results reported for children in
developed countries (Simone et al., 1978).
The absence of radiotherapy in the
treatment modality of our patients would
not adequately explain these poor results,
because treatment failure in our "ade-
quately treated" patients resulted mainly
from marrow relapse rather than CNS
relapse. Although 11 of the 19 (58%)
Ibadan children with ALL fell within the
prognostically favourable age range of 2-7
years, it would appear that the common
presence of other poor-risk factors, like
marked leucocytosis (Jacquillat et al.,
1973; Glidewell & Holland, 1973, unpub-
lished), L2 lymphoblast morphology
(Miller et al., 1979) and absent or low PAS
reaction ofthe lymphoblasts (Lilleyman et
al., 1979; Palmer et al., 1980), contributed
to the overall poor outcome for ALL
patients. The prognostic significance ofthe
intermediate state of haemoglobinization
(Hann et al., 1981) of most of our patients
is not clear. The results in Patients 15 and
17 (Table II) suggested that high PAS
block positivity was an important positive
risk factor. However, the poor outcome in
Patient 16 would suggest that some yet
unidentified prognostic factor could have
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played an additional role among our
patients.
From observations reported in this
series, it would appear that the so-called
"standard risk ALL" (i.e. ALL at 2-7
years of age with a WBC count < 1010/1
and a good response to chemotherapy) is a
rare disease in our part of the world. As
outlined in Tables II and III the clinical
features of ALL and AML in Ibadan
children are different from those reported
forCaucasian children, andfurtherinvesti-
gation ofthese differences is required.
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